{"id":"https://openalex.org/W2015710074","doi":"https://doi.org/10.1111/dom.12276","title":"Pharmacodynamics of the glucagon\u2010like peptide\u20101 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin","display_name":"Pharmacodynamics of the glucagon\u2010like peptide\u20101 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-12","ids":{"openalex":"https://openalex.org/W2015710074","doi":"https://doi.org/10.1111/dom.12276","mag":"2015710074","pmid":"https://pubmed.ncbi.nlm.nih.gov/24524806","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4312941"},"language":"en","primary_location":{"id":"doi:10.1111/dom.12276","doi":"https://doi.org/10.1111/dom.12276","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12276","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12276","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2015710074"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12276","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052412166","display_name":"Yutaka Seino","orcid":"https://orcid.org/0000-0002-1099-7989","observed_orcids":["https://orcid.org/0000-0002-1099-7989"]},"institutions":[{"id":"https://openalex.org/I2800996768","display_name":"Kansai Electric Power (Japan)","ror":"https://ror.org/03xrg8731","country_code":"JP","type":"company","lineage":["https://openalex.org/I2800996768"]},{"id":"https://openalex.org/I4210123101","display_name":"Kansai Electric Power Hospital","ror":"https://ror.org/02srt1z47","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210123101"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Y. Seino","raw_affiliation_strings":["Kansai Electric Power Hospital Osaka Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kansai Electric Power Hospital Osaka Japan","institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006493051","display_name":"Akiyoshi Takami","orcid":"https://orcid.org/0000-0002-1822-9976","observed_orcids":["https://orcid.org/0000-0002-1822-9976"]},"institutions":[{"id":"https://openalex.org/I4210141885","display_name":"Sanofi (Japan)","ror":"https://ror.org/040h02z76","country_code":"JP","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210141885"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Takami","raw_affiliation_strings":["Sanofi K.K. Tokyo Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi K.K. Tokyo Japan","institution_ids":["https://openalex.org/I4210141885"]}]},{"author_position":"middle","author":{"id":null,"display_name":"G. Boka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018075036","display_name":"Sanofi (France)","ror":"https://ror.org/02n6c9837","country_code":"FR","type":"company","lineage":["https://openalex.org/I3018075036"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Boka","raw_affiliation_strings":["Sanofi Chilly Mazarin France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Chilly Mazarin France","institution_ids":["https://openalex.org/I3018075036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039117287","display_name":"Elisabeth Niemoeller","orcid":"https://orcid.org/0009-0004-4900-6259","observed_orcids":["https://orcid.org/0009-0004-4900-6259"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Niemoeller","raw_affiliation_strings":["Sanofi Frankfurt Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanofi Frankfurt Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012472100","display_name":"D. Raccah","orcid":"https://orcid.org/0000-0002-3769-8970","observed_orcids":["https://orcid.org/0000-0002-3769-8970"]},"institutions":[{"id":"https://openalex.org/I4210134195","display_name":"H\u00f4pital Sainte-Marguerite","ror":"https://ror.org/0338wkj94","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487","https://openalex.org/I4210134195"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. Raccah","raw_affiliation_strings":["University Hospital Sainte\u2010Marguerite Marseille France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Sainte\u2010Marguerite Marseille France","institution_ids":["https://openalex.org/I4210134195"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the PDY6797 investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"on behalf of the PDY6797 investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5052412166"],"corresponding_institution_ids":["https://openalex.org/I2800996768","https://openalex.org/I4210123101"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":{"value":5380,"currency":"USD","value_usd":5380},"fwci":2.6537,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.89347712,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"16","issue":"8","first_page":"739","last_page":"747"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":1.0},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9419999718666077},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9210000038146973},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.925000011920929},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9850000143051147},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6299999952316284},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.546999990940094},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.9973297119140625},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8690697550773621},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8118937015533447},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.758028507232666},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7017968893051147},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6156756281852722},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5343922972679138},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5313692092895508},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5011403560638428},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.46675682067871094},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4535868465900421},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42235735058784485},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.35974276065826416},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.31009626388549805},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.24515312910079956},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000067757","descriptor_name":"Glucagon-Like Peptide-1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000067758","descriptor_name":"Glucagon-Like Peptide-2 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D044465","descriptor_name":"White People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054795","descriptor_name":"Incretins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1111/dom.12276","doi":"https://doi.org/10.1111/dom.12276","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12276","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12276","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3288806","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4312941","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4312941","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4312941/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Obes Metab","raw_type":"Text"},{"id":"pmid:24524806","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24524806","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.776.8777","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.776.8777","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/b8/9c/dom0016-0739.PMC4312941.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1111/dom.12276","doi":"https://doi.org/10.1111/dom.12276","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.12276","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.12276","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320324809","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22"},{"id":"https://openalex.org/F4320334966","display_name":"Bhabha Atomic Research Centre","ror":"https://ror.org/05w6wfp17"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2015710074.pdf","grobid_xml":"https://content.openalex.org/works/W2015710074.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1483095253","https://openalex.org/W1484868350","https://openalex.org/W1485176679","https://openalex.org/W1489142781","https://openalex.org/W1511301354","https://openalex.org/W1557767719","https://openalex.org/W1582261481","https://openalex.org/W1584571461","https://openalex.org/W1776821951","https://openalex.org/W1854533075","https://openalex.org/W1928513790","https://openalex.org/W1964398497","https://openalex.org/W1971751459","https://openalex.org/W1998717083","https://openalex.org/W2012425163","https://openalex.org/W2041551639","https://openalex.org/W2043092889","https://openalex.org/W2045753702","https://openalex.org/W2060104918","https://openalex.org/W2062304895","https://openalex.org/W2082213840","https://openalex.org/W2090244618","https://openalex.org/W2095774646","https://openalex.org/W2097132878","https://openalex.org/W2098905490","https://openalex.org/W2108122035","https://openalex.org/W2111047373","https://openalex.org/W2154067841","https://openalex.org/W2154717294","https://openalex.org/W2160565799","https://openalex.org/W2169189827","https://openalex.org/W2320739850","https://openalex.org/W2520432709","https://openalex.org/W3141319229","https://openalex.org/W4213000396","https://openalex.org/W4234314368"],"related_works":["https://openalex.org/W1969897150","https://openalex.org/W2036454215","https://openalex.org/W2045188930","https://openalex.org/W1482710124","https://openalex.org/W2619128140","https://openalex.org/W1584571461","https://openalex.org/W2256173852","https://openalex.org/W2943099799","https://openalex.org/W2132196305"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,64],"PDY6797":[2],"study":[3,133],"evaluated":[4],"efficacy,":[5],"safety":[6,227],"and":[7,13,41,44,99,121,180,187,223,228],"pharmacodynamics":[8],"of":[9,38,52,158,240],"lixisenatide":[10,39,53,88,119,151,163,185,237],"in":[11,69,93,114,139,144,214,238,242],"Japanese":[12,140,231],"Caucasian":[14],"patients":[15,215,232],"with":[16,24,118,135,150,184,216,219,236],"type":[17],"2":[18],"diabetes":[19],"mellitus":[20],"(T2DM)":[21],"insufficiently":[22],"controlled":[23],"sulphonylureas":[25,220],"with/without":[26,221],"metformin.":[27],"METHODS:":[28],"This":[29],"randomized,":[30],"double-blind,":[31],"placebo-controlled":[32],"trial":[33],"comprised":[34],"a":[35,45,81,225],"single-dose":[36],"assessment":[37,51],"5":[40,54],"10":[42],"\u00b5g,":[43],"5-":[46],"to":[47,55],"6-week":[48],"repeated":[49],"dose-escalation":[50],"30":[56],"\u00b5g":[57,165],"once":[58],"(QD)":[59],"or":[60],"twice":[61],"daily":[62],"(BID).":[63],"primary":[65],"endpoint":[66],"was":[67,123,167,197],"change":[68],"postprandial":[70],"plasma":[71,101],"glucose":[72,102],"(PPG)":[73],"area":[74],"under":[75],"the":[76,85,156,162,170,210],"curve":[77],"(AUC)[0:29-4:30":[78],"h]":[79,117,147,206],"after":[80],"standardized":[82],"breakfast":[83],"at":[84,209],"highest":[86,211],"tolerated":[87],"dose.":[89],"Change":[90,111],"from":[91,112,174],"baseline":[92,113,175],"glycated":[94],"haemoglobin":[95],"(HbA1c),":[96],"2-h":[97,177],"PPG":[98,115,145,204,243],"fasting":[100],"(FPG)":[103],"were":[104,107,148,182],"assessed,":[105],"as":[106],"adverse":[108],"events.":[109],"RESULTS:":[110],"AUC[0:29-4:30":[116,146,205],"QD":[120,152,186],"BID":[122,188],"significantly":[124,202],"greater":[125],"than":[126],"placebo":[127,190,208],"(p":[128,191],"<":[129,192],"0.0001":[130],"for":[131,176,194],"all":[132],"populations),":[134],"particularly":[136],"prominent":[137],"effects":[138],"patients.":[141],"Greater":[142],"reductions":[143,241],"seen":[149],"versus":[153,189,207],"BID,":[154],"while":[155],"totality":[157],"evidence":[159],"suggested":[160],"that":[161],"20":[164],"dose":[166,213],"optimal.":[168],"In":[169],"overall":[171],"population,":[172],"changes":[173],"PPG,":[178],"HbA1c":[179],"FPG":[181],"significant":[183],"0.01":[193],"all).":[195],"Lixisenatide":[196,201],"well":[198],"tolerated.":[199],"CONCLUSIONS:":[200],"reduced":[203],"well-tolerated":[212],"T2DM":[217],"treated":[218],"metformin":[222],"had":[224],"good":[226],"tolerability":[229],"profile.":[230],"experienced":[233],"particular":[234],"benefits":[235],"terms":[239],"excursions.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2015710074","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
